RhumbLine Advisers’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
|
|||||
|
2025
Q1 | $465K | Buy |
|
|||||
|
2024
Q4 | $297K | Buy |
|
|||||
|
2024
Q3 | $150K | Sell |
|
|||||
|
2024
Q2 | $124K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $116K | Buy |
|
|||||
|
2021
Q4 | $174K | Sell |
|
|||||
|
2021
Q3 | $293K | Buy |
|
|||||
|
2021
Q2 | $445K | Sell |
|
|||||
|
2021
Q1 | $432K | Sell |
|
|||||
|
2020
Q4 | $228K | Buy |
|
|||||
|
2020
Q3 | $179K | Sell |
|
|||||
|
2020
Q2 | $237K | Buy |
|
|||||
|
2020
Q1 | $156K | Hold |
|
|||||
|
2019
Q4 | $206K | Buy |
|
|||||
|
2019
Q3 | $188K | Sell |
|
|||||
|
2019
Q2 | $222K | Buy |
|
|||||
|
2019
Q1 | $199K | Sell |
|
|||||
|
2018
Q4 | $166K | Buy |
|
|||||
|
2018
Q3 | $136K | Sell |
|
|||||
|
2018
Q2 | $118K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $143K | Buy |
|
|||||
|
2016
Q4 | $74K | Sell |
|
|||||
|
2016
Q3 | $117K | Buy |
|
|||||
|
2016
Q2 | $136K | Buy |
|